Autopsy report · NCT01516476
Study of RO6807952 in Patients With Diabetes Mellitus Type 2
Cause of deathNo reason given
Life of this trial
- Registered 2 months after it had already started.
- Ran for about 2 months before it stopped.
- 2 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Hoffmann-La Roche
- Sponsor type
- Industry
- Conditions
- Diabetes Mellitus Type 2
- Interventions
- Placebo; RO6807952; RO6807952; liraglutide
- Participants
- 2
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.